12.2 Pulmonary Rehabilitation & COPD Management

ABPMR Physical Medicine and Rehabilitation Board Exam Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Exam Overview

1.1 ABPMR Part I Exam Overview & Format 1.2 Board Review Strategy & Content Blueprint Breakdown

2 Chapter 2: Musculoskeletal Medicine

2.1 Shoulder & Upper Extremity Diagnostics 2.2 Knee, Hip & Lower Extremity Conditions 2.3 Spine Pathology, Radiculopathy & Myelopathy 2.4 Inflammatory Arthritis, Tendinopathies & Concussion 2.5 Bone Health, Osteoporosis & Metabolic Bone Disease 2.6 Thoracic Outlet Syndrome & Peripheral Nerve Entrapment 2.7 Fracture Rehabilitation & Immobilization Complications 2.8 Overuse Tendinopathies & Regenerative Medicine 2.9 Gait Analysis & Abnormal Gait Patterns

3 Chapter 3: Spinal Cord Injury Rehabilitation

3.1 ASIA Examination & Impairment Scale 3.2 Spinal Cord Injury Syndromes 3.3 Autonomic Dysreflexia & Acute Complications 3.4 Neurogenic Bladder, Bowel & Secondary Complications

4 Chapter 4: Stroke & Neuromuscular Rehabilitation

4.1 Stroke Vascular Syndromes & Acute Assessment 4.2 Stroke Motor Recovery & Hemiplegic Complications 4.3 Spasticity Assessment & Multimodal Management 4.4 ALS, GBS, CIDP & Neuromuscular Disease Rehab 4.5 Multiple Sclerosis & Demyelinating Disease Rehabilitation 4.6 Parkinsonism, Movement Disorders & Functional Neurologic Disorder

5 Chapter 5: Electrodiagnostics (EMG/NCS)

5.1 Nerve Conduction Studies Principles & Physics 5.2 Needle Electromyography & MUAP Analysis 5.3 Mononeuropathies & Radiculopathy Patterns 5.4 Neuromuscular Junction Disorders & Myopathies

6 Chapter 6: Traumatic Brain Injury

6.1 TBI Severity Classification, Glasgow Coma Scale, and Pathophysiology 6.2 Rancho Los Amigos Levels of Cognitive Functioning and Disability Rating Scale 6.3 Neurobehavioral Sequelae and Agitation Management 6.4 Concussion Evaluation, Vestibular-Ocular Dysfunction, and Return-to-Play/Work Protocols

7 Chapter 7: Chronic Pain & Interventional Spine

7.1 Fluoroscopic Spine Interventions 7.2 Opioid Stewardship & Controlled Substance Compliance 7.3 Complex Regional Pain Syndrome, Fibromyalgia & Myofascial Pain 7.4 Spinal Cord Stimulation & Intrathecal Therapy

8 Chapter 8: Amputee Rehabilitation & Prosthetics

8.1 Amputation Surgical Levels & Medicare K-Levels 8.2 Socket Designs & Suspension Systems 8.3 Prosthetic Feet & Microprocessor Knee Mechanisms 8.4 Post-Amputation Care, Residual Limb & Phantom Pain

9 Chapter 9: Pediatric Rehabilitation

9.1 Cerebral Palsy Classification & GMFCS 9.2 Spina Bifida & Myelomeningocele Management 9.3 Muscular Dystrophies & Neuromuscular Disease in Children 9.4 Pediatric Brachial Plexopathy & Congenital Disorders

10 Chapter 10: Prosthetics, Orthotics & Assistive Technology

10.1 Lower Limb Orthoses — AFOs & KAFOs 10.2 Spinal & Upper Extremity Orthoses 10.3 Upper Limb Prosthetics — Body-Powered vs Myoelectric 10.4 Wheelchairs, Seating Systems & Pressure Mapping

11 Chapter 11: Medical Rehabilitation & Outcomes

11.1 Dysphagia Assessment & Management 11.2 Neurogenic Bladder & Bowel Management 11.3 Pressure Injuries & Wound Management 11.4 Outcome Measures & Medical Complications 11.5 Cancer Rehabilitation & Oncologic Rehabilitation 11.6 Burns, Endocrine/Metabolic & Medical Complications Rehabilitation

12 Chapter 12: Cardiopulmonary Rehabilitation

12.1 Cardiac Rehabilitation Phases & Metabolic Equivalents 12.2 Pulmonary Rehabilitation & COPD Management

13 Chapter 13: Foundational Rehabilitation Concepts

13.1 Kinesiology, Biomechanics & Functional Anatomy 13.2 Rehabilitation Pharmacology & Medication Management 13.3 Research Methodology, Biostatistics & Evidence-Based Practice 13.4 Nutrition, Metabolism & Energy Expenditure in Rehabilitation 13.5 Diagnostic Procedures: Imaging, MSK Ultrasound, Urodynamics & Neuropsych Assessment

12.2 Pulmonary Rehabilitation & COPD Management

Key Takeaways Explain This Topic AI

COPD diagnosis requires post-bronchodilator spirometry demonstrating FEV1/FVC < 0.70. GOLD spirometric staging is based on post-bronchodilator FEV1 % predicted: GOLD 1 (Mild, FEV1 >= 80%), GOLD 2 (Moderate, 50% <= FEV1 < 80%), GOLD 3 (Severe, 30% <= FEV1 < 50%), and GOLD 4 (Very Severe, FEV1 < 30%).

Pulmonary rehabilitation is a multidisciplinary program incorporating lower extremity aerobic exercise, upper extremity ergometry (reconditioning accessory respiratory muscles), patient education, and energy conservation techniques.

Pursed-lip breathing creates positive expiratory backpressure (auto-PEEP effect), keeping small airways open during expiration, decreasing dynamic hyperinflation (air trapping), slowing respiratory rate, and relieving dyspnea.

Inspiratory Muscle Training (IMT) utilizing threshold pressure devices targeted at 30% to 50% of Maximum Inspiratory Pressure (MIP/Pimax) strengthens diaphragmatic muscles and improves exertional dyspnea in patients with muscle weakness (MIP <= 60 cm H2O).

Long-Term Supplemental Oxygen Therapy (LTOT) improves survival in severe resting hypoxemia (PaO2 <= 55 mmHg or SpO2 <= 88%; or PaO2 56-59 mmHg / SpO2 89% with cor pulmonale, pulmonary hypertension, or erythrocytosis Hct > 55%). Target resting SpO2 is 88% to 92%.

Last updated: July 2026

Overview of Pulmonary Rehabilitation & COPD

Chronic Obstructive Pulmonary Disease (COPD) is a major cause of chronic morbidity characterized by non-fully reversible airflow limitation resulting from small airway disease (chronic bronchitis) and parenchymal destruction (emphysema). Pulmonary rehabilitation is an evidence-based, multidisciplinary intervention designed to reduce symptoms, decrease disability, improve exercise capacity, and enhance quality of life in patients with chronic respiratory disease.

• COPD Spirometric Staging (GOLD Criteria)
• Spirometric Diagnostic Criterion

A clinical diagnosis of COPD requires post-bronchodilator spirometry demonstrating a forced expiratory volume in 1 second to forced vital capacity ratio ( F E V 1 / F V C < 0.70 FEV_1/FVC < 0.70 FE V 1 ​ / F V C < 0.70 ).

Spirometric Staging of Airflow Obstruction

Once airflow obstruction is established, severity is classified into four GOLD Spirometric Stages based on post-bronchodilator F E V 1 FEV_1 FE V 1 ​ percent predicted :

GOLD 1 (Mild COPD) : F E V 1 ≥ 80 % FEV_1 \ge 80\% FE V 1 ​ ≥ 80% of predicted. Chronic cough or sputum production may be present; exertional dyspnea is mild.

GOLD 2 (Moderate COPD) : 50 % ≤ F E V 1 < 80 % 50\% \le FEV_1 < 80\% 50% ≤ FE V 1 ​ < 80% of predicted. Shortness of breath on exertion; patients commonly present to care at this stage.

GOLD 3 (Severe COPD) : 30 % ≤ F E V 1 < 50 % 30\% \le FEV_1 < 50\% 30% ≤ FE V 1 ​ < 50% of predicted. Severe reduction in airflow, marked exertional breathlessness, and frequent exacerbations.

GOLD 4 (Very Severe COPD) : F E V 1 < 30 % FEV_1 < 30\% FE V 1 ​ < 30% of predicted. Severe airflow limitation, chronic respiratory failure, pulmonary hypertension, and cor pulmonale.

GOLD Stage Severity Post-Bronchodilator F E V 1 / F V C FEV_1/FVC FE V 1 ​ / F V C Post-Bronchodilator F E V 1 FEV_1 FE V 1 ​ (% Predicted) Clinical & Functional Impact

GOLD 1 Mild < 0.70 ≥ 80% Mild chronic cough; largely normal exertion.

GOLD 2 Moderate < 0.70 50% – 79% Dyspnea on brisk walking; reduced exercise tolerance.

GOLD 3 Severe < 0.70 30% – 49% Dyspnea during basic ADLs; frequent exacerbations.

GOLD 4 Very Severe < 0.70 < 30% Resting dyspnea; high risk of cor pulmonale and hypercapnia.

• Core Components of Pulmonary Rehabilitation
• Exercise Training Regimen

Lower Extremity Aerobic Conditioning : Treadmill walking or cycle ergometry at 60% to 80% of peak work rate for 20 to 30 minutes, 3 to 5 days per week. Aerobic conditioning increases muscle oxidative enzymes, reduces lactate accumulation, and lowers minute ventilation requirements at submaximal workloads.

Upper Extremity Resistance & Ergometry : Unsupported arm elevation or arm ergometry. Upper extremity activities (e.g., grooming, dressing) require shoulder girdle muscles (pectoralis major, serratus anterior, scalenes) to act as arm fixators. In COPD patients with hyperinflation, this deprives the chest wall of accessory respiratory support, causing severe breathlessness. Upper extremity reconditioning reduces metabolic demand during arm elevation, improving ADL tolerance.

Interval Training : Alternating high-intensity exercise bursts (e.g., 1–3 minutes at 80%–90% peak capacity) with rest periods for patients unable to tolerate continuous exercise due to breathlessness.

Energy Conservation & Postural Techniques

Pacing & Task Simplification : Structuring daily tasks to conserve energy, exhaling during exertion (e.g., exhaling when lifting), and using adaptive tools.

Tripod Position : Leaning forward with hands or elbows supported on knees or a table. This fixes the pectoral girdle, optimizing the mechanical advantage of accessory respiratory muscles and enhancing diaphragmatic leverage.

• Breathing Retraining Techniques
• Pursed-Lip Breathing (PLB)

Technique : Inhale slowly through the nose for 2 seconds, then exhale gently through pursed lips for 4 seconds (1:2 inspiration-to-expiration ratio).

Physiological Mechanism : Generates positive expiratory backpressure (an auto-PEEP effect ) within the bronchial tree during exhalation. This maintains intraluminal airway pressure above intrapleural pressure, preventing the premature dynamic collapse of small, non-cartilaginous airways damaged by emphysema.

Clinical Benefits : Reduces dynamic hyperinflation (air trapping), increases tidal volume, decreases respiratory rate, and relieves exertional dyspnea.

Diaphragmatic Breathing (Abdominal Breathing)

Technique : Inhale through the nose while consciously expanding the abdomen outward and keeping upper chest movement minimal.

Physiological Mechanism : Re-establishes diaphragmatic movement and minimizes recruitment of accessory upper chest muscles (scalenes, sternocleidomastoids).

Clinical Precaution : In severe COPD with flattened diaphragms (Hoover's sign), diaphragmatic breathing may increase work of breathing and requires close monitoring.

Breathing Technique Mechanical Mechanism Primary Physiological Effect Clinical Indications

Pursed-Lip Breathing Generates positive expiratory backpressure (auto-PEEP effect) Prevents small airway collapse, decreases air trapping, lowers HR/RR Exertional dyspnea, dynamic hyperinflation, emphysema

Diaphragmatic Breathing Enhances abdominal wall motion during inspiration Increases diaphragmatic excursion, suppresses accessory muscle overuse Mild-to-moderate COPD, resting dyspnea

Inspiratory Muscle Training Applies threshold resistance against inspiratory airflow ( 30 % – 50 % P i m a x 30\%–50\% P_{imax} 30%–50% P ima x ​ ) Increases diaphragm strength, muscle thickness, inspiratory endurance Inspiratory muscle weakness ( M I P ≤ 60 cm H 2 O MIP ≤ 60\text{ cm H}_2\text{O} M I P ≤ 60 cm H 2 ​ O ), refractory dyspnea

• Inspiratory Muscle Training (IMT)
• Indications & Protocol

Selection Criteria : Indicated for COPD patients with documented inspiratory muscle weakness, defined as a Maximum Inspiratory Pressure ( M I P or P i m a x MIP \text{ or } P_{imax} M I P or P ima x ​ ) ≤ 60 cm H 2 O \le 60\text{ cm H}_2\text{O} ≤ 60 cm H 2 ​ O , or persistent dyspnea despite standard rehabilitation.

Methodology : Uses a spring-loaded threshold pressure trainer requiring a baseline negative pressure to open a valve.

Prescription : Intensity is set at 30% to 50% of measured MIP , performed for 15 to 30 minutes daily for 6 to 12 weeks, with weekly load progression.

Outcomes : Increases inspiratory muscle strength, reduces dyspnea, and improves 6-minute walk distance (6MWT).

• Supplemental Long-Term Oxygen Therapy (LTOT)
• Evidence & Mortality Benefit

Long-Term Supplemental Oxygen Therapy (LTOT) is one of the few medical interventions proven to prolong survival in patients with severe chronic resting hypoxemia when worn continuously ( ≥ 15 hours/day \ge 15\text{ hours/day} ≥ 15 hours/day ).

Clinical Indications for LTOT

Absolute Criterion (Group I) : Resting arterial oxygen tension P a O 2 ≤ 55 mmHg PaO_2 \le 55\text{ mmHg} P a O 2 ​ ≤ 55 mmHg OR resting pulse oximetry S p O 2 ≤ 88 % SpO_2 \le 88\% Sp O 2 ​ ≤ 88% on room air at rest.

Relative Criterion (Group II) : Resting P a O 2 = 56 to 59 mmHg PaO_2 = 56\text{ to } 59\text{ mmHg} P a O 2 ​ = 56 to 59 mmHg OR resting S p O 2 = 89 % SpO_2 = 89\% Sp O 2 ​ = 89% COMBINED with ≥ 1 \ge 1 ≥ 1 of:

Cor Pulmonale or dependent peripheral edema.

Pulmonary Hypertension (P pulmonale, RVH on ECG/Echo).

Secondary Erythrocytosis (hematocrit > 55 % > 55\% > 55% ).

Exertional or Nocturnal Hypoxemia : Prescribed if S p O 2 ≤ 88 % SpO_2 \le 88\% Sp O 2 ​ ≤ 88% occurs exclusively during exercise or sleep.

Titration Goals & Safety

Target S p O 2 SpO_2 Sp O 2 ​ Range : Oxygen is titrated (1–3 L/min nasal cannula) to achieve a resting S p O 2 SpO_2 Sp O 2 ​ of 88% to 92% .

Oxygen-Induced Hypercapnia : Excessive high-flow oxygen can worsen hypercapnia via reversal of hypoxic pulmonary vasoconstriction (worsening V / Q V/Q V / Q mismatch), the Haldane effect, and suppression of hypoxic ventilatory drive.

LTOT Category Oxygen Oximetry / ABG Criteria Required Co-Morbidities Recommended Goal & Duration

Absolute Indication (Group I) Resting P a O 2 ≤ 55 mmHg PaO_2 \le 55\text{ mmHg} P a O 2 ​ ≤ 55 mmHg ; OR Resting S p O 2 ≤ 88 % SpO_2 \le 88\% Sp O 2 ​ ≤ 88% None required Titrate S p O 2 SpO_2 Sp O 2 ​ to 88%–92% ; Wear ≥ 15 hours/day (continuous)

Relative Indication (Group II) Resting P a O 2 = 56 – 59 mmHg PaO_2 = 56–59\text{ mmHg} P a O 2 ​ = 56–59 mmHg ; OR Resting S p O 2 = 89 % SpO_2 = 89\% Sp O 2 ​ = 89% Must have ≥ 1 of :; • Cor pulmonale / dependent edema; • Pulmonary hypertension; • Erythrocytosis (Hct > 55%) Titrate S p O 2 SpO_2 Sp O 2 ​ to 88%–92% ; Wear ≥ 15 hours/day (continuous)

Exertional / Nocturnal Hypoxemia S p O 2 ≤ 88 % SpO_2 \le 88\% Sp O 2 ​ ≤ 88% during exertion or sleep only None required Portable O2 prescribed for exercise or sleep to maintain S p O 2 ≥ 90 % SpO_2 \ge 90\% Sp O 2 ​ ≥ 90%